San Antonio · San Francisco · Seattle · Silicon Valley · St. Louis · Tampa Bay ... Biotech says therapy helps patients keep weight off post-GLP-1.
News
- Dean Kamen-founded ARMI to complete biomanufacturing center by 2027 - Boston Business Journal
- CellRight Technologies, LLC Announces Update and Senior Leadership Changes
CellRight announces Senior leadership changes, implementation of new commercial plan and cost reduction initiatives. SAN ANTONIO, TX / ACCESS ...
- 1 in 4 ABC patients treated with Novartis Kisqali remain progression-free beyond 4 years
A fully integrated, R&D-driven biotechnology company listed on the Hong Kong Stock Exchange (1672.HK). ... biotech entity) and Shaoxing ...
- Pfizer's Tukysa delays HER2 breast cancer progression as 1st-line maintenance therapy
... San Antonio Breast Cancer Symposium. Patients who received the Pfizer ... Fierce Biotech · Fierce Healthcare · Fierce Pharma. Our Events. Life ...
- BriaCell (BCTX) Highlights Promising Data at 2025 SABCS Symposium - GuruFocus
Key Takeaways: BriaCell Therapeutics (BCTX) presented promising Phase 2 and 3 trial data at the 2025 San Antonio Breast Cancer Symposium.